Moreover, high systemic levels of IL-6 are shown to be associated with late AMD, and low serum levels of TNF-α have been described to be linked with increased visual acuity after anti-VEGF therapy for nAMD [98,99]. This evidence concerns the gene VEGFA and age-related macular degeneration.